Business Description
Cosmos Health Inc
NAICS : 423460
SIC : 5122
ISIN : US2214133058
Total Employee Number:
163Compare
Compare
Traded in other countries / regions
COSM.USAV67A.Germany IPO Date
2010-05-19Description
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.88 | |||||
Debt-to-EBITDA | -1.06 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2.62 | |||||
Beneish M-Score | -3.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -56.5 | |||||
3-Year EBITDA Growth Rate | 52.3 | |||||
3-Year EPS without NRI Growth Rate | 72.6 | |||||
3-Year FCF Growth Rate | 67 | |||||
3-Year Book Growth Rate | -50.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.27 | |||||
9-Day RSI | 59.86 | |||||
14-Day RSI | 52.18 | |||||
3-1 Month Momentum % | -14.93 | |||||
6-1 Month Momentum % | -49.32 | |||||
12-1 Month Momentum % | -37.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.08 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 31.61 | |||||
Days Sales Outstanding | 89.88 | |||||
Days Payable | 79.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -57.1 | |||||
Shareholder Yield % | -57.86 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 10.4 | |||||
Operating Margin % | -25.75 | |||||
Net Margin % | -30.41 | |||||
EBITDA Margin % | -23.73 | |||||
FCF Margin % | -13.64 | |||||
OCF Margin % | -13.42 | |||||
ROE % | -93.04 | |||||
ROA % | -33.4 | |||||
ROIC % | -37.07 | |||||
3-Year ROIIC % | -79.42 | |||||
ROC (Joel Greenblatt) % | -81.36 | |||||
ROCE % | -60.53 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 23.62 | |||||
PS Ratio | 0.12 | |||||
PB Ratio | 0.59 | |||||
Price-to-Tangible-Book | 0.94 | |||||
EV-to-EBIT | -1.76 | |||||
EV-to-EBITDA | -1.91 | |||||
EV-to-Revenue | 0.45 | |||||
EV-to-Forward-Revenue | 0.36 | |||||
EV-to-FCF | -3.33 | |||||
Price-to-GF-Value | 0.66 | |||||
Price-to-Median-PS-Value | 0.13 | |||||
Earnings Yield (Greenblatt) % | -56.82 | |||||
FCF Yield % | -64.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:COSM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cosmos Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 69.487 | ||
| EPS (TTM) ($) | -0.64 | ||
| Beta | 1.4747 | ||
| 3-Year Sharpe Ratio | -0.43 | ||
| 3-Year Sortino Ratio | -0.72 | ||
| Volatility % | 149.99 | ||
| 14-Day RSI | 52.18 | ||
| 14-Day ATR ($) | 0.033918 | ||
| 20-Day SMA ($) | 0.217285 | ||
| 12-1 Month Momentum % | -37.32 | ||
| 52-Week Range ($) | 0.1616 - 1.32 | ||
| Shares Outstanding (Mil) | 62.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cosmos Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cosmos Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 132 days | ||
| Second quarter earnings results for 2026 | 2026-08-18 | In 45 days | ||
| General meeting for 2026 | 2026-07-15 09:00 | In 12 days | ||
| First quarter earnings results for 2026 | 2026-05-20 | 0.28 (-5.83%) | ||
| Annual report for 2025 | 2026-04-15 | 0.33 (+2.77%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.73 (-4.39%) | ||
| General meeting for 2025 | 2025-09-30 09:00 | 1.07 (-2.73%) | ||
| Second quarter earnings results for 2025 | 2025-08-18 | 0.90 (+5.33%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 0.45 (-9.34%) | ||
| Annual report for 2024 | 2025-04-15 | 0.34 (-5.00%) |
Show
Entries
Cosmos Health Inc Frequently Asked Questions
What is Cosmos Health Inc(COSM)'s stock price today?
The current price of COSM is $0.24. The 52 week high of COSM is $1.32 and 52 week low is $0.16.
When is next earnings date of Cosmos Health Inc(COSM)?
The next earnings date of Cosmos Health Inc(COSM) is 2026-08-18 Est..
Does Cosmos Health Inc(COSM) pay dividends? If so, how much?
Cosmos Health Inc(COSM) does not pay dividend.
Guru Commentaries on NAS:COSM
No articles.
Press Release
Articles on Cosmos Health Inc
No articles.
Headlines
See More- 1
Jun 17, 2026
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
Benzinga • 8:27am
Jun 11, 2026
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers